MLTX
Price
$40.92
Change
-$1.05 (-2.50%)
Updated
May 10, 6:59 PM EST
88 days until earnings call
PHIO
Price
$0.70
Change
-$0.07 (-9.09%)
Updated
May 10, 6:59 PM EST
Ad is loading...

MLTX vs PHIO

Header iconMLTX vs PHIO Comparison
Open Charts MLTX vs PHIOBanner chart's image
MoonLake Immunotherapeutics
Price$40.92
Change-$1.05 (-2.50%)
Volume$321.09K
CapitalizationN/A
Phio Pharmaceuticals
Price$0.70
Change-$0.07 (-9.09%)
Volume$33.43K
CapitalizationN/A
View a ticker or compare two or three
MLTX vs PHIO Comparison Chart

Loading...

MLTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PHIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MLTX vs. PHIO commentary
May 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a StrongSell and PHIO is a Sell.

COMPARISON
Comparison
May 13, 2024
Stock price -- (MLTX: $40.92 vs. PHIO: $0.70)
Brand notoriety: MLTX and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 130% vs. PHIO: 13%
Market capitalization -- MLTX: $2.57B vs. PHIO: $3.23M
MLTX [@Biotechnology] is valued at $2.57B. PHIO’s [@Biotechnology] market capitalization is $3.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 2 TA indicator(s) are bullish while PHIO’s TA Score has 4 bullish TA indicator(s).

  • MLTX’s TA Score: 2 bullish, 5 bearish.
  • PHIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -9.59% price change this week, while PHIO (@Biotechnology) price change was -14.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.77%. For the same industry, the average monthly price growth was -5.00%, and the average quarterly price growth was +67.78%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 08, 2024.

PHIO is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-1.77% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MLTX with price predictions.
OPEN
A.I.dvisor published
a Summary for PHIO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MLTX($2.57B) has a higher market cap than PHIO($3.24M). PHIO YTD gains are higher at: -7.303 vs. MLTX (-32.240).
MLTXPHIOMLTX / PHIO
Capitalization2.57B3.24M79,536%
EBITDAN/AN/A-
Gain YTD-32.240-7.303441%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PHIO: Fundamental Ratings
PHIO
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXPHIO
RSI
ODDS (%)
Bullish Trend 3 days ago
60%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
41%
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
46%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
36%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
MLTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PHIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DGLRX22.050.12
+0.55%
BNY Mellon Global Stock - I
CAFCX33.890.09
+0.27%
American Funds AMCAP 529C
KMVAX31.360.06
+0.19%
Kirr Marbach Partners Value
FDESX36.510.02
+0.05%
Fidelity Advisor Diversified Stock O
RMDCX2.62N/A
N/A
Virtus Silvant Mid-Cap Growth C

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with SYRE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-2.50%
SYRE - MLTX
41%
Loosely correlated
+4.94%
BCYC - MLTX
39%
Loosely correlated
-2.93%
ORIC - MLTX
32%
Poorly correlated
-5.37%
BNTC - MLTX
31%
Poorly correlated
+0.76%
PHVS - MLTX
30%
Poorly correlated
+4.33%
More